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Abstract 246 Words 
Purpose Few studies have investigated the relationship between solar ultraviolet radiation (UV) and 
childhood hematological malignancies (CHM). This study addresses the associations between 
residential UV exposure at diagnosis and the incidence of types and subtypes of CHM, by age and 
gender, in France, over a long period, on the fine scale of the 36,326 Communes that constitute 
mainland France. Methods The 9,082 cases of acute leukemia (AL) and 3,563 cases of lymphoma 
diagnosed before the age of 15 years from 1990 to 2009 were provided by the French National 
Registry of Childhood Hematological Malignancies. The incidence of CHM was calculated by 
Commune, year, age and gender and expressed as the standardized incidence ratio (SIR). UV data 
from 1988 to 2007 were extracted from the EUROSUN database. Results The annual daily average UV 
exposure of the children ranged from 85.5 to 137.8 J/cm2. For each additional 25 J/cm2 there was a 
significant increase in precursor B-cell acute lymphoblastic leukemia (PBC-ALL) in children aged less 
than 5 years (SIR: 1.18; 95%CI: 1.10-1.27). Further analysis of PBC-ALL in the young children 
suggested a better fit of models with a threshold, with the risk increasing above 100 J/cm2, for which 
the SIR was 1.24 (95%CI: 1.14-1.36) for a 25 J/cm² increase. The results remained stable in analyses 
stratifying by deprivation index or degree of urbanization of the Communes. Conclusion The study 
suggests that higher residential UV exposure may be positively associated with a higher incidence of 
PBC-ALL in early childhood. 
I. Introduction 
Acute leukemia (AL) and lymphoma are the most frequent childhood hematological malignancies 
(CHM). Several genetic diseases and polymorphisms[1], and non-genetic exposures (including 
ŝŽŶŝǌŝŶŐ ƌĂĚŝĂƚŝŽŶ ĂŶĚ ? ĨŽƌ ,ŽĚŐŬŝŶ ?Ɛ ĂŶĚ ƵƌŬŝƚƚ ?Ɛ ůǇŵƉŚŽŵĂ ? ƉƐƚĞŝŶ Ăƌƌ ǀŝƌƵƐ ? ĂƌĞ ŬŶŽǁŶ ƌŝƐŬ
factors. Some factors related to early immune stimulations and environmental exposures (pesticide 
use at home and, for AL, extremely low frequency electromagnetic fields) are also suspected[2, 3]. 
Solar ultraviolet (UV) radiation, UVA (315 - 400 nm) and UVB (280 - 315 nm), exposures are 
ubiquitous with marked gradients within and between countries.  
Solar UV radiation, a known risk factor for skin cancers[4], plays a role in vitamin D synthesis and, 
through this mechanism, has also been identified as a potential protective factor for some cancers[5, 
6]. UV radiation, especially UVB radiation, may also induce systemic immune suppression. Animal 
study findings have raised the question of whether UV radiation may influence the development of 
hematological malignancies by means of its immunosuppressive effect[7 ?9].  
The effects of UV radiation on human health are multiple and complex, and may act in positive or 
negative ways on the emergence of hematological malignancies. The general population's exposure 
to solar UV radiation is known to have increased in recent decades. In addition to experimental 
biological investigations of the association between UV radiation and the incidence of hematological 
malignancies, the results of which are still not conclusive, epidemiological studies have been 
conducted. The results are mixed for adults and only four studies have been published for children.  
The association between the incidence of non-,ŽĚŐŬŝŶ ?ƐůǇŵƉŚŽŵĂ (NHL) and UV radiation exposure 
among adults has been much studied in the last 20 years. However, the results remain a subject of 
debate. Most North-American studies and a few others, including pooled studies, have found an 
inverse association between UV radiation exposure and NHL incidence[10 ?13]. However, some 
studies found a positive association[14 ?16]. There have been few studies of ůĞƵŬĞŵŝĂĂŶĚ,ŽĚŐŬŝŶ ?Ɛ
lymphoma, and UV radiation exposure. Most of the studies conducted have found an inverse 
association between UV radiation and cancer incidence [17 ?20]. An ecological study in Japan found a 
positive correlation between UVB radiation level and leukemia mortality risk, but only for two 
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ƐƵďƚǇƉĞƐ P  ?ůǇŵƉŚŽŝĚ ůĞƵŬĞŵŝĂ ? ĂŶĚ  ?ŽƚŚĞƌ ŵĂůŝŐŶĂŶƚ ŶĞŽƉůĂƐŵƐ ŽĨ ůǇŵƉŚŽŝĚ ĂŶĚ ŚŝƐƚŝŽĐǇƚŝĐ
ƚŝƐƐƵĞ ?[21]. 
To the authors' knowledge, four studies, with different designs and sample sizes, on the association 
between childhood hematological malignancies and UV radiation exposure have been published. 
Three studies found a negative association, for leukemia [22,24] and/or NHL [23,24], while the fourth 
study [25] showed an increased risk of lymphoblastic leukemia in 2-4-year-old children during the 
light season (April-September). 
In that context, the objective of the present study was to analyze the association between population 
exposure to UV radiation and the incidence of types and subtypes of CHM, over a long time period. 
II. Materials and Methods 
The association between the UV exposure of the subjects' places of residence at the time of 
diagnosis and the incidence rates of CHM was studied. For this purpose, quantitative estimates of 
average annual exposures to UV radiation for the 1988-2007 period of the 36,326 French Communes, 
the smallest administrative subdivisions of the country, were associated with the incidence data of 
the corresponding Communes of France by year, age and gender.  
Cases, time period, geographic units and population counts 
The CHM cases were provided by the French National Registry of Childhood Hematological 
Malignancies (NRCH)[26]. Since 1990, the registry has included all the malignant or borderline 
hematological diseases occurring in children aged less than 15 years residing in mainland France at 
the time of diagnosis. For each case, the registry provided the date of birth, date of diagnosis and 
address where the child was living at the time of diagnosis. All the CHM cases diagnosed between 
1990 and 2009 and having a known residential Commune at diagnosis were included (99.9% of the 
cases). For the study period (1990-2009), 9,082 cases of AL and 3,563 cases of lymphoma were 
included. 
An incidence study was performed at the Commune level over the study period. The cases consisted 
in all children diagnosed with AL or lymphoma before the age of 15 years and registered in the NRCH 
during the period. The annual national CHM incidence rates estimated by the NRCH, by age and 
gender, were used as reference rates. The annual estimates of the Commune populations, by year of 
age and gender, were provided by the French National Institute for Statistics and Economic Research 
(INSEE) for the census years: 1990, 1999, 2006, 2007, 2008 and 2009. For the other years, the 
estimates for the Communes were interpolated using the annual estimates provided by INSEE for the 
96 French mainland Départements (larger administrative units with an average of 360 Communes per 
Département).  
UV radiation exposure at the time of diagnosis  
UV radiation exposure data were provided by the European EUROSUN project, the aims of which are 
to quantify sun exposure in Europe and its effects on health. The European Meteosat satellites 
provided images from which an assessment of solar surface irradiance (SSI) was obtained for the 
1988-2007 period (HelioClim-1 database for 1988-2005, HelioClim-3 database for 2004-2007). SSI is 
the solar irradiance observed at ground level on horizontal surfaces and is integrated over the whole 
spectrum[27]. An algorithm enables derivation of the spectral distribution every 10 nm from the total 
irradiance observations. The EUROSUN data provide an assessment of UVA and UVB radiation in 
Europe on a 5 x 5 km grid. Each Commune was allocated the annual average UVA and UVB radiation 
estimated at the location of the town hall. The spatial correlation between UVB and UVA radiation 
exposures was almost equal to 1. Consequently, the associations of UVA and UVB radiation 
exposures with CHM could not be analyzed separately and the exposure variable used for a given 
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Commune was therefore the daily average UV (UVA+UVB) radiation exposure over the period 1988-
2007. 
Statistical analysis 
All analyses were implemented with SAS v9.3 software. 
The standardized incidence ratio (SIR) was used to characterize the spatial differentials of incidence 
over the study period. The SIR was calculated as the ratio of the observed number of cases to the 
corresponding expected number of cases obtained from the Commune numbers of at-risk person-
years (PY), by age (1 year) and gender, and the national annual age- and gender-specific incidence 
rates.  
Poisson regressions were fitted for all the analyses using the Communes of residence at diagnosis as 
the basic statistical unit, with their expected number of cases (Ei) as the offsets and observed number 
of cases (Oi) as the observations. As most of the analyses which were performed on this small scale 
led to under-dispersion, Communes were grouped using the decile of the covariate of interest.  
Since there were no prior hypotheses with regard to the shape of the relationship between leukemia 
or lymphoma incidence and sun exposure, two models were compared using the log-likelihood test 
to determine the degree of adequacy of a log-linear association. In the first model, the UV radiation 
exposure variable was qualitative and categorized to obtain UV radiation based geographic zoning, 
which consisted of 10 groups of Communes  ? “ĚĞĐŝůĞƐ ? ?Dk, k=1, ? ?10 with equal pediatric populations 
(0-14 years): ݈݊ܧሺܱ௞ሻ ൌ ሺܧ௞ሻ ൅  ? ߚ௛ଵ଴௛ୀଵ Ǥ ܺ௛, 
In which: 
- E(Ok) is the expected value of the observed number of cases (Ok) in decile Dk of the Communes, and 
Ek is the expected number of cases, 
- Xh is an indicator variable with a value of 1 for decile Dh and 0 for the other deciles, and ßh is the 
corresponding regression coefficient.  
For the second model, a semi-quantitative discrete UV radiation variable was built: ݈݊ܧሺܱ௞ሻ ൌ ሺܧ௞ሻ ൅ ߙ଴ ൅ ߚǤܷ ௞ܸ, 
in which ܷ ௞ܸ is the pediatric population weighted average value of the UV radiation exposure in 
decile Dk . In this model, ݁ఉ estimated the SIR variation with an increase of 1 UV radiation unit. In this 
study, one UV radiation unit is equal to an increase of 25 J/cm², which is about half of the UV 
radiation range for the Communes. 
A value of the deviance/degrees of freedom ratio greater than 2 was considered to indicate an over-
dispersed model. In the event of over-dispersion that was not explained by a more adequate model, 
a negative binomial error was used instead of the Poisson error.  
Considering the shape of some of the associations between ܷ ௞ܸ and the SIR, even when log-linearity 
was not formally rejected, a model with a segmented linear regression with one change point (߬) was 
also fitted to some observed CHM counts:  ݈݊ܧሺܱ௞ሻ ൌ ሺܧ௞ሻ ൅ ߙଵ ൅ ߚǤ ሺܷ ௞ܸ െ ߬ሻା, 
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in which ܷ ௞ܸ is the pediatric population weighted average value of the UV radiation exposure in the 
decile, Dk, ሺܷ ௞ܸ െ ߬ሻା is the positive part of ሺܷ ௞ܸ െ ߬ሻ which takes the value zero if ܷ ௞ܸч߬ and 
(ܷ ௞ܸ- ߬) otherwise. In order to determine whether there was convincing evidence of a change point 
and determine the best change point, segmented linear regressions were fitted to the observations 
with values of ߬ every 2 J/cm² and the AIC criterion was used to identify the best model.  
The regression models included no term of spatial autocorrelation even though exposures to UV are 
spatially correlated, since previous analyses of the data had not shown any spatial auto-correlation 
between CHM rates in France[28 ?30]. 
Analyses were performed by type and subtype of CHM, by age group and gender. The study had a 
statistical power of 80% for underlying exact SIR less than 0.85 or greater than 1.15 for most types of 
CHM with a two-sided Poisson test at the 5% level for a general pediatric population exposure 
frequency of 10%.  
The stability of the results was first assessed by examining their consistency across three time 
periods (1990-1996, 1997-2003, 2004-2008) and five large geographic subdivisions of France (Paris 
area, North-West, North-East, South-East, South-West). 
In order to account for potential confounding or effect modification, analyses were repeated after 
stratification by, or adjustment for, the urban status and socio-demographic characteristics of the 
Communes extracted from the 1999 census data. The French deprivation index FDep99[31] was 
defined as the first component (68% of the total variation) of a principal component analysis of four 
census variables: median income of the households, proportion of blue-collar workers, proportion of 
unemployed and proportion of baccalaureate (high school diploma) holders.  
In a parallel analysis, the correlation between Commune sun exposure at birth and at diagnosis was 
estimated with data from two national population-based case-control studies conducted by the 
authors' team. The ESCALE study was conducted between 2003 and 2004 and included 763 AL cases 
and 1,681 controls [32]. The ESTELLE study was conducted between 2010 and 2011 and included 747 
AL cases and 1,421 controls [33].   
III. Results 
UV (UVA+UVB) radiation exposure varied between 85.5 and 137.8 J/cm² with a median of 100.2 
J/cm². A clear north-south gradient of UV radiation exposure was observed, together with locally 
slightly higher UV radiation exposures in the Paris area and Alsace region (Figure 1). 
The main subtypes of leukemia were acute lymphoblastic leukemia (ALL), which accounted for 82.0% 
of all AL and acute myeloid leukemia (AML), which accounted for 16.3% of all AL (Table 1). The 
lymphomas consisted in 58.7% non-,ŽĚŐŬŝŶ ?ƐůǇŵƉŚŽŵĂ ?E,> ?and 41.3й,ŽĚŐŬŝŶ ?ƐůǇŵƉŚŽŵĂ ? 
UV radiation exposure was positively associated with the incidence of AL (Table 2), with a significant 
log-linear trend. The association was limited to ALL, with a 9% increase in SIR (SIR=1.09;95%CI [1.03-
1.14]) for an increase of 25 J/cm². A positive linear trend was found and was borderline significant for 
NHL, particularly the Burkitt subtype. However, the overall heterogeneity test for the ten deciles of 
exposure was clearly not significant (Table 3).  
Age at diagnosis significantly interacted with UV radiation exposure (p=0.007). The association 
between UV radiation exposure and ALL was only observed for children aged less than 5 years 
(SIR=1.16;95%CI [1.08-1.25]) (Supplementary table A). For the children aged more than 5 years, the 
SIR was almost equal to 1 and not significant. In contrast, gender had no significant modifying effect 
(Supplementary table B).  
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The results were also heterogeneous across the three main subtypes of ALL (p=0.036). A positive and 
still very highly significant association only remained for PBC-ALL, the most common ALL subtype 
with 5,977 cases (Table 2). The modifying effect of age at diagnosis also remained significant for PBC-
ALL (p=0.035) (Table 4). A positive linear trend, borderline significant, was found for the 10-14 years 
age group. However, the heterogeneity test was not significant and the shape of the association was 
quite different from that of the 0-4 years age group. 
The association between UV radiation exposure and the incidence of PBC-ALL in young children did 
not seem to be linear over the whole range of UV radiation exposure since the SIR were significantly 
greater than 1 only in the last three UV radiation exposure deciles (Table 4). Threshold log-linear 
Poisson regressions were adjusted with various possible values of the threshold and the clearly 
bestfit with the data was obtained with a threshold value of 100 J/cm². The corresponding SIR was 
1.24 (95%CI [1.14-1.36]) for a 25 J/cm² difference in UV exposure among Communes exposed to 
100 J/cm² or more (Table 4 and Supplementary figure). 
The associations observed between residential UV radiation exposure and PBC-ALL diagnosed before 
age 5 years in the three time periods (1990-1996, 1997-2003, 2004-2009) were very similar, and no 
modifying effect of time period on the association between UV radiation exposure and PBC-ALL 
diagnosed before age 5 years was observed (Table 5). 
Analyzing this association across 5 large French regions (North-East, Paris area, North-West, South-
West, South-East) showed that it was positive and significant in the South-East region (SIR = 1.25; 
95%CI [1.07, 1.45]), where UV radiation exposure is both greater on average than in the other 
regions and more variable (Table 5). In the South-West and North-West, the association was positive 
but not statistically significant. The UV radiation exposure variability in the Paris area was so limited 
that it could not be considered separately. This was also practically the case for the North East 
region, where the population exposed to more than 100J/cm² was very small (2.7%). However, when 
the South-East was excluded, the association between PBC-ALL diagnosed before age 5 years and UV 
radiation exposure was positive and significant (SIR: 1.46; 95%CI [1.14-1.87] for a 25-unit increase in 
UV above 100 J/cm²). Overall, there was no statistically significant modifying effect of the UV 
radiation PBC-ALL association by region (p=0.63). 
A significant log-linear trend between PBC-ALL incidence and a French deprivation index (Fdep) was 
observed, with a slightly higher incidence of PBC-ALL before age 5 years in less deprived Communes 
(p=0.03). No modifying or confounding effect of this variable on the association between Commune 
UV radiation exposure and PBC-ALL diagnosed before age 5 years was evidenced. Sensitivity analyses 
on the South East of France, the region with the highest and most variable UV radiation exposure, 
which was also the region where the Fdep was most associated with PBC-ALL, did not show any 
modifying effect of Fdep on the association between UV radiation exposure and PBC-ALL (data not 
shown). 
No association between PBC-ALL and urban status was observed (p=0.51). No modifying or 
confounding effect of urban status on the association between UV radiation exposure and PBC-ALL 
before age 5 years was observed (data not shown). 
 Considering the ESCALE and ESTELLE case-control data, a strong correlation (r) between the sun 
exposure of the Commune of residence of the controls at birth and that of their Commune of 
residence at inclusion in the study was found, especially for the youngest children (aged less than 5 
years) (r = + 0.90 for ESCALE and ESTELLE). 
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IV. Discussion  
There was a positive association between the Commune spatial variability of UV radiation exposure 
and that of the incidence of PBC-ALL for the children aged less than 5 years in France for the period 
1990-2009. No significant association was evidenced for the other CHM or at other ages. The 
association observed was the same for both genders, and was not modified by time period. No 
regional heterogeneity was observed. Stratification by, or adjustment for, a French deprivation index 
(Fdep99) and an urban unit variable did not significantly change the association between UV 
radiation exposure and the incidence of PBC-ALL in young children. 
The power of the comparisons was evaluated a priori to be greater than 80% for SIR less than 0.85 or 
greater than 1.15 for most types of CHM, for a frequency of exposure of 10%. Even though multiple 
comparisons were performed by studying the association for each type of CHM, subtype of leukemia, 
age group, gender, and some potential confounding factors, the statistical significance level of the 
association and its consistency with respect to several stratifications do not suggest a random 
association. 
The strengths of this study consist in the objectivity of the sun exposure data, available on a fine 
scale (Communes), and the exhaustiveness and high quality of the incidence data, and the long time 
period studied, which enabled large numbers of CHM cases to be studied by type and subtype. The 
population studied was relatively homogeneous and lived over a large area with a fairly wide 
distribution of UV radiation exposures. 
Because of the very high spatial correlation between UVA and UVB, it was not possible to distinguish 
their associations with CHM.  
Although the Commune UV radiation exposures were highly auto-correlated, an auto-correlated 
structure for the observed Poisson count was not considered relevant as the dependent variable was 
not spatially auto-correlated in any of the studies conducted in France. The small yearly variations in 
CHM incidence that had previously been observed[34] were taken into account in the estimates of 
the expected number of cases for each Commune.  
As a result of the highly auto-correlated and smooth continuous spatial variation of Commune sun 
exposure, the sun exposure in the Commune of residence at inclusion in the study for the controls, 
was very closely correlated with that of the Commune of birth in two large population based case-
control studies conducted by the authors' team on the same population of children (ESCALE: 2003-
2004 and ESTELLE: 2010-2011). It is therefore unlikely that the findings of this study are dependent 
on considering the Commune at birth rather than the Commune at diagnosis. As a result, the 
association observed cannot be specifically related to a particular exposure time window for the 
children or their parents: before conception, during pregnancy, at birth, since birth, around 
diagnosis.  
The present study detected a positive spatial correlation between a population exposure index, 
Commune sun exposure, and Commune PBC-ALL incidence in young children. Even though it is likely 
that this association does exist in the French pediatric population it may be either a direct individual 
association or, alternatively, reflect the effect of some other unknown individual or Commune 
characteristics, which are related to residential sun exposure and influence the incidence of this 
particular group of ALL. This is not the case for the increased incidence of children leukemia that has 
been observed in France in the close vicinity of nuclear power plants[35] or high voltage power 
lines[3]. Both increased incidences are very localized spatially and cannot explain the trend 
association found in this study. 
Of the four studies published on the association between residential sun exposure and CHM, three 
used very different methods, populations or exposure variables, compared to those used herein. The 
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international study conducted by Musselman and Spector [22] found an inverse association between 
sun exposure and leukemia (lymphoid and acute non-lymphocytic leukemia), and, after adjusting on 
a socioeconomic index, no significant association with lymphoma, as in the present study. The 
exposure was assessed by the absolute latitude and by an annual solar radiation measurement based 
on NASA data. The study was conducted on a very large scale, in 57 countries (some partially 
covered), located on different continents. The Greek study [23] found an inverse association 
between NHL and individual sun exposure. The study was based on interviews and measured 
individual sun exposure in a country with a very different level of UV radiation exposure to that in 
France.  In addition, the association reported was based on a limited number of subjects (87 NHL 
cases, 164 controls). A large Finnish study [25], which included 7,423 cases between 1964 and 2003, 
both adults and children, found, in a subgroup analysis, lower numbers of ALL in the dark season 
among children aged 2-4 years. The results were quite similar to those of the present study.  
The study[24] most similar to the present study in terms of methods and power was a large 
Californian study, which included 10,476 cases and 207,568 controls. The exposure assessment was 
ecological and obtained from a geostatistical model that estimated ground level UV radiation from 
UV radiation measurement station data. An inverse relationship was found for ALL and Non-
,ŽĚŐŬŝŶ ?Ɛ ůǇŵƉŚŽŵĂĨŽƌĐŚŝůĚƌĞŶ  ?-5 years old. In contrast, the present study showed a significant 
positive association between sun exposure at diagnosis and PBC-ALL in young children (less than 5 
years old) and no significant association with lymphoma. The Californian study analyzed sun 
exposure at birth and it may be that the correlation between sun exposure at birth and at diagnosis 
for the Californian children is not as strong as that observed in France. Furthermore, California has a 
different level of UV radiation exposure than France, as the maximum yearly average residential 
exposure to sun in France (137.8 J/cm2) is less than the first quartile of exposure in the Californian 
study (148.4 J/cm2). In addition, large fractions of the Californian population have different skin 
pigmentations and lifestyles. These may also contribute to explaining the different results. The 
Californian study recorded ĚĂƚĂŽŶ ?ĞƚŚŶŝĐŝƚǇ ? and the authors found a negative association with UV 
radiation exposure for children with Hispanic mothers (Hispanics were the largest ethnic group in the 
study) and African-American mothers, but not for children with Caucasian mothers.  In the present 
study, no information on  ?ĞƚŚŶŝĐŝƚǇ ? was available, but the majority of the French population is of 
Caucasian origin. 
V. Conclusion 
This study suggests a positive geographic association between population residential UV radiation 
exposure greater than 100 J/cm² and the incidence of PBC-ALL, essentially for children under the age 
of 5 years. The systemic immune suppression induced by UV radiation may be a biological hypothesis 
for this finding. However, further ecological studies are necessary in order to replicate this result in 
other populations and investigate whether these findings are due to other spatially heterogeneous 
ecological factors that are associated with both population residential sun exposure and the 
particular subgroup of ALL. An additional question is whether there is an association between the 
individual UV radiation exposure of the child/mother/father and the risk of CHM. Investigation for 
such an association could only be conducted in the context of individual case-control studies and, 
possibly, sufficiently large cohort studies, which include precise individual information on exposure 
to sun and take into account individual childhood leukemia risk factors potentially associated with 
individual UV radiation exposure. Future studies should also address residential history, skin type and 
other factors that may be correlated with UV radiation exposure. Meanwhile, irrespective of whether 
the association is direct or not, it should be considered and taken into account in other spatial 
studies of the variability of childhood leukemia incidences rates in relation to other factors including 
environmental and behavioral factors. 
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Table 1: Distribution of childhood hematological malignancies, by age and gender (France 1990-2009) 
  Boys   Girls   Both 
  0-4 years 5-9 years 10-14 years Total   0-4 years 5-9 years 10-14 years Total   0-4 years 5-9 years 10-14 years Total 
Leukemia                             
ALL 2030 1321 832 4183 
 
1746 953 561 3260 
 
3776 2274 1393 7443 
 PBC-ALL 1765 849 498 3112  1630 792 443 2865  3395 1641 941 5977 
B-ALL 72 115 63 250  27 39 19 85  99 154 82 335 
T-ALL 164 345 262 771  72 111 92 275  236 456 354 1046 
AML 351 171 226 748  343 175 210 728  694 346 436 1476 
NOS AL  45 28 29 102  30 18 13 61  75 46 42 163 
Total 2426 1520 1087 5033 
 
2119 1146 784 4049 
 
4545 2666 1871 9082 
Lymphoma 
              
NHL 293 621 569 1483 
 
132 216 260 608 
 
425 837 829 2091 
   Lymphoblastic 75 121 145 341 
 
44 40 62 146 
 
119 161 207 487 
   Burkitt 167 357 239 763 
 
46 85 59 190 
 
213 442 298 953 
   Mature 51 143 184 378  42 90 137 269  93 233 321 647 
HL 56 255 551 862  10 81 519 610  66 336 1070 1472 
Total 349 876 1120 2345   142 297 779 1218   491 1173 1899 3563 
               
                              AL: Acute leukemia; ALL: Acute lymphoblastic leukemia; AML: Acute myeloblastic leukemia; PBC-ALL: precursor B-cell ALL ; B-ALL: Burkitt-cell Leukemia;T-ALL: T-cell ALL; AL NOS : Not 
otherwise specified AL; ,> P,ŽĚŐŬŝŶ ?ƐůǇŵƉŚŽŵĂ ?E,> Pnon-,ŽĚŐŬŝŶ ?ƐůǇŵƉŚŽŵĂ 
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Table 2: Incidence of childhood leukemia (ages 0-14) by decile of UV radiation exposure (France, 1990-2009) 
 
  Acute Leukemia (AL) Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) 
UV radiation deciles (J/cm
²
) O E SIR  95% CI O E SIR  95% CI O E SIR  95% CI 
[85.5-90.3]  923 913.4 1.01 0.95-1.08 751 748.6 1 0.93-1.08 159 148.6 1.07 0.92-1.25 
]90.3-94.1] 888 893.4 0.99 0.93-1.06 725 732.2 0.99 0.92-1.06 140 145.3 0.96 0.82-1.14 
]94.1-97.2] 888 904 0.98 0.92-1.05 705 741.2 0.95 0.88-1.02 159 146.7 1.08 0.93-1.27 
]97.2-99.1] 919 909.6 1.01 0.95-1.08 739 745.6 0.99 0.92-1.07 166 147.7 1.12 0.97-1.31 
]99.1-100.2] 1082 1170.5 0.92 0.87-0.98 861 958.1 0.9 0.84-0.96 198 191.3 1.04 0.90-1.19 
]100.2-100.9] 633 654.9 0.97 0.89-1.04 534 537.1 0.99 0.91-1.08 91 106.1 0.86 0.70-1.05 
]100.9-105.5] 920 955.2 0.96 0.90-1.03 774 783.2 0.99 0.92-1.06 129 154.8 0.83 0.70-0.99 
]105.5-109.3] 938 874.8 1.07 1.01-1.14 771 716.8 1.08 1.00-1.15 145 142.3 1.02 0.87-1.20 
]109.3-123.9] 925 903.6 1.02 0.96-1.09 778 740.7 1.05 0.98-1.13 140 146.6 0.96 0.81-1.13 
]123.9-137,8] 966 902.7 1.07 1.00-1.14 805 739.6 1.09 1.02-1.17 149 146.7 1.02 0.86-1.19 
Total 9082 9082     7443 7443     1476 1476     
p for heterogeneity
a
     0.03       0.01       0.24   
p for departure from log-linearity
b
     0.11       0.09       0.19   
Trend by unit of 25 J/cm²      1.06 1.01-1.11     1.09 1.03-1.14
 
     0.97 0.86-1.08
 
 
   Precursor B-cell ALL (PBC-ALL) Burkitt-cell Leukemia (B-ALL) T-cell  ALL (T-ALL) 
UV radiation deciles O E SIR  95% CI O E SIR 95% CI O E SIR  95% CI 
[85.5-90.3] 581 599.8 0.97 0.89-1.05 40 33.8 1.18 0.87-1.61 122 106.2 1.15 0.96-1.37 
]90.3-94.1] 552 586.8 0.94 0.87-1.02 52 33.1 1.57 1.20-2.06 109 103.9 1.05 0.87-1.27 
]94.1-97.2] 571 594.3 0.96 0.89-1.04 27 33.5 0.81 0.55-1.18 98 104.9 0.93 0.77-1.14 
]97.2-99.1] 607 599.1 1.01 0.94-1.10 24 33.5 0.72 0.48-1.07 97 104.5 0.93 0.76-1.13 
]99.1-100.2] 666 773.8 0.86 0.80-0.93 47 42.4 1.11 0.83-1.48 136 131 1.04 0.88-1.23 
]100.2-100.9] 444 433 1.03 0.93-1.13 25 23.9 1.05 0.71-1.55 61 74.1 0.82 0.64-1.06 
]100.9-105.5] 615 628.5 0.98 0.90-1.06 40 35.4 1.13 0.83-1.54 112 110.4 1.01 0.84-1.22 
]105.5-109.3] 638 575.2 1.11 1.03-1.20 24 32.4 0.74 0.50-1.11 101 101 1.00 0.82-1.21 
]109.3-123.9] 653 593.4 1.1 1.02-1.19 27 33.7 0.8 0.55-1.17 93 105.3 0.88 0.72-1.08 
]123.9-137.8] 650 593.1 1.1 1.01-1.18 29 33.5 0.87 0.60-1.25 117 104.7 1.12 0.93-1.34 
Total 5977 5977     335 335     1046 1046     
p for heterogeneity
a
     <0.0001       0.02       0.43   
p for departure from log-linearity
b
 
    0.31       0.06       0.34   
Trend by unit of 25 J/cm²     1.12 1.03-1.22     0.75 0.57-0.97     1.00 0.87-1.15 
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E = Expected number of cases; O = Observed number of cases; SIR and 95% CI = Standardized Incidence ratio and its 95% confidence interval 
 
a
p-value of the test for heterogeneity of the SIR observed across the 10 strata of UV radiation exposure; 
b
p-value of the test for departure from log-linearity of the SIR  
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Table 3: Incidence of childhood lymphoma (ages 0-14) by decile of UV radiation exposure (France, 1990-2009) 
  Lymphoma Non-Hodgkin's lymphoma (NHL) Hodgkin's lymphoma (HL) 
UV radiation deciles (J/cm
2
) O E SIR  95% CI O E SIR  95% CI O E SIR  95% CI 
[85.5-90.3]  297 361.7 0.82 0.73-0.92 176 212.2 0.83 0.72-0.96 121 149.5 0.81 0.68-0.97 
]90.3-94.1] 384 354.4 1.08 0.98-1.20 221 207.7 1.06 0.93-1.21 163 146.8 1.11 0.95-1.29 
]94.1-97.2] 347 358.1 0.97 0.87-1.08 192 209.9 0.91 0.79-1.05 155 148.3 1.05 0.89-1.22 
]97.2-99.1] 334 355.3 0.94 0.84-1.05 200 208.8 0.96 0.83-1.10 134 146.5 0.91 0.77-1.08 
]99.1-100.2] 495 440.1 1.12 1.03-1.23 291 260.8 1.12 0.99-1.25 204 179.3 1.14 0.99-1.31 
]100.2-100.9] 257 249.8 1.03 0.91-1.16 139 147.7 0.94 0.80-1.11 118 102.1 1.16 0.97-1.38 
]100.9-105.5] 373 376.9 0.99 0.89-1.10 221 221.0 1.00 0.88-1.14 152 155.9 0.98 0.83-1.14 
]105.5-109.3] 346 345.1 1.00 0.90-1.11 220 202.2 1.09 0.95-1.24 126 143.0 0.88 0.74-1.05 
]109.3-123.9] 360 362.0 0.99 0.90-1.10 222 211.1 1.05 0.92-1.20 138 150.9 0.91 0.77-1.08 
]123.9-137,8] 370 359.6 1.03 0.93-1.14 209 209.8 1.00 0.87-1.14 161 149.9 1.07 0.92-1.25 
Total 3563 3563     2091 2091     1472 1472     
p for heterogeneity
a
     0.01       0.08       0.03   
p for departure from log-linearity
b
     0.28       0.09       0.26   
Trend by unit of 25 J/cm²      1.05 0.94-1.17
 
     1.06 0.97-1.17
 
     1.02 0.88-1.20
 
 
  Lymphoblastic-NHL Mature-NHL Burkitt-NHL 
UV radiation deciles (J/cm
2
) O E SIR  95% CI O E SIR  95% CI O E SIR  95% CI 
[85.5-90.3]  32 49.3 0.65 0.46-0.92 60 65.8 0.91 0.71-1.17 83 96.6 0.86 0.69-1.07 
]90.3-94.1] 61 48.3 1.26 0.98-1.62 73 64.4 1.13 0.90-1.43 87 94.5 0.92 0.75-1.14 
]94.1-97.2] 49 48.8 1.00 0.76-1.33 60 65.1 0.92 0.72-1.19 83 95.5 0.87 0.70-1.08 
]97.2-99.1] 45 48.6 0.93 0.69-1.24 55 64.6 0.85 0.65-1.11 100 95.2 1.05 0.86-1.28 
]99.1-100.2] 70 60.9 1.15 0.91-1.45 86 80.1 1.07 0.87-1.33 134 119.3 1.12 0.95-1.33 
]100.2-100.9] 30 34.4 0.87 0.61-1.25 44 45.4 0.97 0.72-1.30 65 67.6 0.96 0.75-1.23 
]100.9-105.5] 54 51.5 1.05 0.80-1.37 65 68.4 0.95 0.75-1.21 101 100.7 1.00 0.83-1.22 
]105.5-109.3] 47 47.1 1.00 0.75-1.33 78 62.7 1.24 1.00-1.55 95 92.0 1.03 0.84-1.26 
]109.3-123.9] 56 49.2 1.14 0.88-1.48 68 65.5 1.04 0.82-1.32 98 96.0 1.02 0.84-1.24 
]123.9-137,8] 43 48.8 0.88 0.65-1.19 58 65.1 0.89 0.69-1.15 107 95.5 1.12 0.93-1.35 
Total 487 487     647 647     953 953     
p for heterogeneity
a
     0.12       0.48       0.55   
p for departure from log-linearity
b
     0.08       0.39       0.81   
Trend by unit of 25 J/cm²      1.01 0.83-1.23     0.99 0.83-1.18     1.14 0.99-1.31 
E = Expected number of cases; O = Observed number of cases; SIR and 95% CI = Standardized Incidence ratio and its 95% confidence interval 
 
a
p-value of the test for heterogeneity of the SIR observed across the 10 strata of exposure to UV ; 
b
p-value of the test for departure from log-linearity of the SIR  
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Table 4: Association between UV radiation exposure and incidence of PBC-ALL by age group at diagnosis (France, 1990-
2009) 
 0-4 years old 5-9 years old 10-14 years old 
UV radiation deciles 
(J/cm²) 
O E SIR 95% CI O E SIR 95% CI O E SIR 95% CI 
[85.5-90.3] 336 337.7 0.99 0.89-1.11 166 166.0 1.00 0.86-1.16 79 96.1 0.82 0.66-1.02 
]90.3-94.1] 309 330.0 0.94 0.84-1.05 165 162.4 1.02 0.87-1.18 78 94.3 0.83 0.66-1.03 
]94.1-97.2] 320 334.6 0.96 0.86-1.07 158 164.5 0.96 0.82-1.12 93 95.2 0.98 0.80-1.20 
]97.2-99.1] 330 341.4 0.97 0.87-1.08 177 164.2 1.08 0.93-1.25 100 93.5 1.07 0.88-1.30 
]99.1-100.2] 387 454.0 0.85 0.77-0.94 179 206.4 0.87 0.75-1.00 100 113 0.88 0.73-1.07 
]100.2-100.9] 245 251.1 0.98 0.86-1.11 121 117.3 1.03 0.86-1.23 78 64.6 1.21 0.97-1.51 
]100.9-105.5] 343 355.4 0.97 0.87-1.07 174 173.3 1.00 0.87-1.17 98 99.8 0.98 0.81-1.20 
]105.5-109.3] 360 325.5 1.11 1.00-1.23 171 158.2 1.08 0.93-1.26 107 91.6 1.17 0.97-1.41 
]109.3-123.9] 371 331.8 1.12 1.01-1.24 171 164.9 1.04 0.89-1.20 111 96.8 1.15 0.95-1.38 
]123.9-137.8] 394 333.6 1.18 1.07-1.30 159 163.7 0.97 0.83-1.13 97 95.8 1.01 0.83-1.24 
Total 3395 3395   1641 1641   941 941   
Heterogeneity p
a
    0.0002    0.68    0.08  
Departure from log-
linearity p
b
 
  0.11    0.58    0.16  
Trend by unit of 25 
J/cm² 
  1.18 1.10-1.27   1.00 0.90-1.12   1.15 1.00-1.32 
Trend with threshold 
c
   1.24 1.14-1.36         
 
E = Expected number of cases; O = Observed number of cases; SIR and 95% CI = Standardized Incidence ratio and its 95% confidence 
interval 
 
a
p-value of the test for heterogeneity of the SIR observed across the 10 strata of UV radiation exposure; 
b
p-value of the test for departure 
from log-linearity of the SIR; 
c
Trend with threshold: the threshold value which achieved the best fit to the data was 100 J/cm
2
, the UVT 
variable is therefore the excess of UV radiation (in units of 25 J/cm
2
) above 100 J/cm
2 ? ƚŚĂƚ ŝƐ P hsd с  ? ŝĨ hs ч  ? ? ? : ?Đŵ2, UVT = (UV- 
 ? ? ? ? ? ? ?ŝĨhsш ? ? ? J/cm2 
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Table 5: Association between UV radiation exposure and incidence of PBC-ALL diagnosed before age 5 years in France 1990-2009, by time period and in 5 French regions 
Variable Strata Min
a
 P10
a
 Median
a
 P90
a
 Max
a
 % pop (<5 years old) >100 J/cm² O E SIR 95% CI 
Periods 1990-1996 85.5 90.3 100.0 123.4 137.8 50.0 1176 1176 1.20 1.03-1.39 
1997-2003 85.5 90.4 100.2 123.6 137.8 51.0 1145 1145 1.29 1.11-1.49 
2004-2009 85.5 90.5 100.2 123.6 137.8 51.7 1074 1074 1.24 1.06-1.45 
Geographic areas South-East 93.8 103.5 116.5 130.8 137.8 96.0 852 784.5 1.25 1.07-1.45 
South-West 96.9 103.2 109.2 113.7 123.7 97.5 426 394.8 1.67 0.88-3.20 
Paris area
b
 97.3 99.1 100.2 100.9 101.7 54.8 - 
North-West 88.2 93.0 97.6 104.4 117.8 26.3 685 682.5 1.12 0.59-2.11 
North-East 85.5 88.7 91.2 98.1 112.1 2.7 800 828.2 0.29 0.003-24.53 
Overall association France 1990-2009 85.5 90.3 100.2 123.5 137.8 50.9 3395 3395 1.24 1.14-1.36 
 
O = Observed number of cases; E = expected number of cases; SIR = Estimated trend in SIR by unit of a 25 J/cm
2
 above 100 J/cm
2 
obtained from the slope of the adjusted Poisson regression of Observed over 
Expected number of cases as a linear function of Commune hsdĞǆƉŽƐƵƌĞ ?ǁŝƚŚhsdс ?ŝĨhsч ? ? ?: ?Đŵ2, UVT = (UV-  ? ? ? ? ? ? ?ŝĨhsш ? ? ? J/cm2); a UV radiation distribution per stratum weighted by the population 
aged less than 5 years; b Paris was excluded because of the very low variability of the UV radiation distribution in that area 
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Figure 1: UV radiation: spatial variations in France, 1988-2007 (J/cm²) 
a
 
 
 
a
 The 36,326 Communes in France 
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Supplementary table A: Association between UV radiation exposure and ALL incidence by age group at diagnosis (France, 
1990-2009) 
   0-4 years old  5-9 years old 10-14 years old 
UV radiation 
deciles (J/cm²) 
O E SIR 95% CI O E SIR 95% CI O E SIR  95% CI 
[85.5-90.3] 380 375.9 1.01 0.91-1.12 236 230.3 1.02 0.90-1.16 135 142.4 0.95 0.80-1.12 
]90.3-94.1] 353 367.2 0.96 0.87-1.07 238 225.3 1.06 0.93-1.20 134 139.7 0.96 0.81-1.14 
]94.1-97.2] 354 372.2 0.95 0.86-1.06 210 228.0 0.92 0.80-1.05 141 141.0 1.00 0.85-1.18 
]97.2-99.1] 362 379.7 0.95 0.86-1.06 239 227.6 1.05 0.93-1.19 138 138.4 1.00 0.84-1.18 
]99.1-100.2] 442 504.8 0.88 0.80-0.96 261 285.7 0.91 0.81-1.03 158 167.7 0.94 0.81-1.10 
]100.2-100.9] 265 279.2 0.95 0.84-1.07 159 162.4 0.98 0.84-1.14 110 95.5 1.15 0.96-1.39 
]100.9-105.5] 380 395.2 0.96 0.87-1.06 243 240.1 1.01 0.89-1.15 151 147.9 1.02 0.87-1.20 
]105.5-109.3] 399 361.9 1.10 1.00-1.22 224 219.2 1.02 0.90-1.17 148 135.7 1.09 0.93-1.28 
]109.3-123.9] 403 368.9 1.09 0.99-1.20 230 228.5 1.01 0.88-1.15 145 143.2 1.01 0.86-1.19 
]123.9-137.8] 438 371.0 1.18 1.08-1.30 234 227.0 1.03 0.91-1.17 133 141.6 0.94 0.79-1.11 
Total  3776 3776     2274 2274     1393 1393     
Heterogeneity 
p=
a
 
    0.0004       0.79       0.83   
Departure from 
log-linearity p=
b
 
    0.12       0.71       0.76   
Trend by unit of 
25 J/cm² 
    1.16 1.08-1.25     1.02 0.93-1.11     1.00 0.89-1.13 
E = Expected number of cases; O = Observed number of cases; SIR and 95% CI = Standardized Incidence ratio and its 95% confidence 
interval; 
a
p-value of the test for heterogeneity of the SIR observed across the 10 strata of UV radiation exposure; 
b
p-value of the test for 
departure from log-linearity of the SIR 
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Supplementary table B: Association between UV radiation exposure and childhood ALL incidence by gender (France, 
1990-2009) 
  Boys Girls 
UV radiation 
deciles 
O E SIR  95% CI O E SIR   95% CI  
[85,5-90,3] 429 422.0 1.02 0.92-1.12 322 326.6 0.99 0.88-1.10 
]90,3-94,1] 423 411.7 1.03 0.93-1.13 302 320.6 0.94 0.84-1.05 
]94,1-97,2] 390 416.5 0.94 0.85-1.03 315 324.7 0.97 0.87-1.08 
]97,2-99,1] 426 418.8 1.02 0.93-1.12 313 326.8 0.96 0.86-1.07 
]99,1-100,2] 484 536.4 0.90 0.83-0.99 377 421.7 0.89 0.81-0.99 
]100,2-100,9] 286 300.8 0.95 0.85-1.07 248 236.3 1.05 0.93-1.19 
]100,9-105,5] 439 440.5 1.00 0.91-1.09 335 342.7 0.98 0.88-1.09 
]105,5-109,3] 403 403.3 1.00 0.91-1.10 368 313.5 1.17 1.06-1.30 
]109,3-123,9] 440 416.9 1.06 0.96-1.16 338 323.8 1.04 0.94-1.16 
]123,9-137,8] 463 416.3 1.11 1.02-1.22 342 323.3 1.06 0.95-1.18 
Total 4183 4183     3260 3260     
Heterogeneity p=
a
     0.10       0.03   
Departure from 
log-linearity p=
b
 
    0.30       0.10   
Trend by unit of 
25 J/cm² 
    1.08 1.01-1.16     1.09 1.01-1.18 
                
E = Expected number of cases; O = Observed number of cases; SIR and 95% CI = Standardized Incidence ratio and its 95% confidence 
interval; 
a
p-value of the test for heterogeneity of the SIR observed across the 10 strata of UV radiation exposure; 
b
p-value of the test for 
departure from log-linearity of the SIR 
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Supplementary figure: Standardized Incidence Ratio (SIR) of PBC-ALL diagnosed before age 5 years in France, 1990-2009, 
as a function of the UV radiation exposure of the Commune of residence at diagnosis 
Observed SIR with 95% CI by UV radiation decile and SIR predicted from the fitted threshold linear model  
 
 
a
 Vertical bars: Observed SIR and 95% confidence limits 
b
 Continuous line: SIR predicted by the model with the best fit (log-linear model with threshold at 100 J/cm
2
) 
 
 
 
